| Not Yet Recruiting | Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients NCT07519057 | Medical University of Warsaw | N/A |
| Recruiting | Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma NCT06254248 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Recruiting | EVR and EPO for Liver Transplant Tolerance NCT06832189 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Not Yet Recruiting | Renal Histopathology and Transcriptomic Analysis in Hepatorenal Syndrome During Liver Transplantation NCT07300709 | The University of Hong Kong | N/A |
| Not Yet Recruiting | A Prospective Study to Evaluate the Efficacy and Safety of Entecavir ODT Conversion in Stable Liver Transplant NCT07267208 | Jongman Kim | Phase 2 |
| Recruiting | Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Gener NCT07291258 | University Medical Center Groningen | — |
| Recruiting | Liver Transplant CGM NCT07216508 | Icahn School of Medicine at Mount Sinai | — |
| Not Yet Recruiting | "A Privacy-protecting Environment for Child Transplants Health Related and Genomic Data Integration in the Eur NCT07194057 | Instituto de Investigación Hospital Universitario La Paz | — |
| Recruiting | Feasibility and Acceptability of a New Tool Promoting a Healthy Lifestyle in Liver and Kidney Transplant Recip NCT07305012 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | N/A |
| Not Yet Recruiting | Perioperative Use of Amino Acids in Recipients of Orthotopic Liver Transplantation as a Renal Protective Facto NCT07004387 | Hospital Dr Sotero del Rio | N/A |
| Not Yet Recruiting | Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Sin NCT06928415 | Zhejiang University | — |
| Recruiting | Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989 | Semmelweis University | — |
| Not Yet Recruiting | To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients NCT06589518 | Jongman Kim | Phase 2 |
| Not Yet Recruiting | FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation NCT06409637 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 1 / Phase 2 |
| Recruiting | Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH NCT06813508 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue NCT07102550 | Choon Hyuck David Kwon | Phase 2 |
| Recruiting | Expanding Liver Transplant Immunosuppression Minimization Via Everolimus NCT06280950 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized NCT06222554 | NYU Langone Health | N/A |
| Recruiting | Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics NCT06635564 | Medical University of Vienna | — |
| Completed | Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts NCT07101718 | Zhejiang University | — |
| Not Yet Recruiting | Platelet Count and Function After Usage of Two Different Cell Saver Devices During Liver Transplant Surgery NCT06357455 | Eduardo Schiffer | N/A |
| Recruiting | Perioperative Analgesia With Erector Spinae Plane Block in Liver Transplant Recipients NCT06857331 | Bogomolets National Medical University | N/A |
| Recruiting | Transitional ePRO Diary Liver (Transitional-ePRO) NCT06342557 | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | — |
| Recruiting | Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates NCT06075745 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Recruiting | Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant R NCT06183892 | RenJi Hospital | N/A |
| Recruiting | Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool NCT06088758 | Massachusetts General Hospital | N/A |
| Completed | Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients NCT06043531 | Virginia Commonwealth University | N/A |
| Recruiting | Fluid Management Strategies on Blood Loss in Liver Transplantation NCT06215404 | National Taiwan University Hospital | N/A |
| Active Not Recruiting | Long-term Mortality Post Liver Transplantation in the Era of Modern Immunosuppression. NCT06636409 | University Hospital, Montpellier | — |
| Withdrawn | Cardiac Risk Assessment Using Standard of Care Versus CTA and Heart Flow FFRct NCT04089969 | Corewell Health East | N/A |
| Unknown | REmote moBile Outpatient mOnitoring in Transplant 2.0 NCT04721288 | University Health Network, Toronto | N/A |
| Recruiting | Structured Data Collection of Patients Undergoing Liver Transplantation and Evaluated for Bone Mineral Metabol NCT06838702 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement NCT05506878 | Jacques E. Chelly | N/A |
| Terminated | A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation NCT05514119 | Mayo Clinic | Phase 2 |
| Unknown | PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing. NCT06036225 | Belfast Health and Social Care Trust | N/A |
| Withdrawn | Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN) NCT05275907 | Northwestern University | Phase 4 |
| Completed | Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurr NCT06720675 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | NRP vs DHOPE vs COR-NMP in ECD-DCD Donation NCT05327478 | Erasmus Medical Center | — |
| Recruiting | Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver Transplan NCT06816303 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | US National OCS Liver Perfusion (OLP) Registry NCT05940857 | TransMedics | — |
| Active Not Recruiting | OCS Liver Perfusion (OLP) Post-Approval Registry NCT05074160 | TransMedics | — |
| Completed | Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation NCT05087550 | Methodist Health System | — |
| Unknown | Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation NCT05051605 | Ain Shams University | — |
| Recruiting | PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC NCT04792801 | University Hospital, Lille | — |
| Active Not Recruiting | Observational Study of Eating Behavior in Patients With Diabetes Mellitus and Obesity Undergoing Liver Transpl NCT06714786 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Terminated | Liver Transplantation With Tregs at UCSF NCT03654040 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Unknown | Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients NCT04867720 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Completed | Early Nutritional Intervention in Patients Undergoing Liver Transplantation NCT07168369 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Completed | Early Versus Routine Drain Removal After Live Liver Donor Hepatectomy NCT04504487 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | Liver Transplantation and Coronavirus Disease 2019 (COVID-19) NCT04695756 | Hospital Italiano de Buenos Aires | — |
| Withdrawn | Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation NCT04383756 | Vanderbilt University Medical Center | EARLY_Phase 1 |
| Unknown | LIFT Intervention in Liver Transplant Candidates NCT04836923 | Northwestern University | N/A |
| Recruiting | Cabozantinib to Treat Recurrent Liver Cancer Post Transplant NCT04204850 | University Health Network, Toronto | Phase 2 |
| Terminated | OCS Liver DCD Trial NCT04194437 | TransMedics | N/A |
| Completed | Quantra QStat in Trauma and Liver Transplant NCT04312958 | HemoSonics LLC | — |
| Completed | Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients. NCT04471441 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Withdrawn | A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant Recipients NCT03515330 | Johns Hopkins University | N/A |
| Unknown | Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant NCT04265157 | Assiut University | — |
| Completed | OCS Liver PROTECT Continued Access Protocol NCT04186221 | TransMedics | N/A |
| Completed | OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study NCT05096754 | TransMedics | — |
| Completed | MicroRNA Profile As a Biomarker of Liver Damage in Different Types of Liver Donors. NCT06611046 | Mar Dalmau | — |
| Completed | The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients NCT03819322 | Fernanda P Silveira, MD, MS | Phase 2 |
| Unknown | Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL) NCT04069065 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Unknown | Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant NCT04035876 | Zhejiang University | Phase 1 / Phase 2 |
| Completed | Controlled Donors After Circulatory Death and Brain Death: a Multicenter Study of Transfusion, One-year Graft NCT04945135 | Hospital Clinic of Barcelona | — |
| Terminated | Efficacy of Ex-situ Normothermic Perfusion Versus Cold Storage in the Transplant With Steatotic Liver Graft. NCT03930459 | Instituto de Investigacion Sanitaria La Fe | N/A |
| Completed | Microbiota Study in Liver Transplanted Patients NCT03507140 | University Hospital, Grenoble | — |
| Active Not Recruiting | Liver Transplantation With Tregs at MGH NCT03577431 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Unknown | Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation NCT03666689 | Assiut University | — |
| Completed | Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine NCT03527238 | University of Florida | Phase 2 |
| Completed | Stented Biliary Anastomosis in Living Donor Liver Transplantation NCT03636321 | Alaa Mstafa Hassan Sewefy | N/A |
| Completed | Copeptin Serum Level in Liver Transplant Recipients NCT03587623 | Medical University of Warsaw | — |
| Completed | Individualized Multimodal Hemostasis Evaluation Pyramid (IMHOTEP) NCT03555383 | Semmelweis University | — |
| Completed | HOPE for Human Extended Criteria and Donation After Brain Death Donor (ECD-DBD) Liver Allografts NCT03124641 | University Hospital, Aachen | N/A |
| Completed | Controlled Attenuation Parameter (CAP) in Liver Allografts NCT02798861 | Andres Duarte-Rojo | — |
| Completed | Eating Behavior, Food Craving and Relation to Excessive Weight Gain in Patients Submitted to Liver Transplanta NCT03411616 | Federal University of Minas Gerais | — |
| Terminated | A Cohort Study of Operationally Tolerant Allograft Recipients NCT02743793 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | A Physical Activity Program in End-state Liver Disease NCT02776553 | University of Arkansas | N/A |
| Completed | Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant NCT02429869 | University of California, San Francisco | Phase 4 |
| Completed | Interest of the Donor-specific Antibodies After Liver Transplantation NCT03238443 | University Hospital, Lille | — |
| Completed | OCS Liver PROTECT Continuation Post-Approval Study NCT05096741 | TransMedics | — |
| Completed | Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplant NCT02533180 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Eating Behaviour and Gustatory Sensitivity Before and After Liver Transplant in Cirrhotic Patients NCT02859506 | Centre Hospitalier Universitaire Dijon | N/A |
| Unknown | Ischemia Time and Graft Survival NCT02521584 | AlRefaey Kandeel | — |
| Completed | Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood NCT02718573 | Icahn School of Medicine at Mount Sinai | — |
| Completed | Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children NCT02182986 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney NCT02057484 | Astellas Pharma Europe Ltd. | — |
| Completed | Increasing Activity in Liver Transplant Patients NCT02058498 | Mayo Clinic | N/A |
| Completed | A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function NCT02040584 | Novartis Pharmaceuticals | Phase 3 |
| Unknown | Cardiac Functions in Living Donor Liver Transplant Recipients. An Echocardiographic Study. NCT01840514 | Mansoura University | — |
| Completed | Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimu NCT01598987 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Text Messaging for Adherence in Adolescent Liver Transplant Recipients NCT01696331 | Stanford University | N/A |
| Terminated | Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation NCT01230502 | University of Wisconsin, Madison | N/A |
| Recruiting | Australian and New Zealand Massive Transfusion Registry NCT02863250 | Monash University | — |
| Completed | Recurrence of Hereditary Hemorrhagic Telangiectasia (HHT) After Liver Transplantation NCT03942315 | Hospices Civils de Lyon | — |
| Unknown | Home-Care Needs in Liver or Renal Transplantation Recipients and Their Spouses NCT01380002 | National Taiwan University Hospital | — |
| Completed | Closed-loop Anaesthesia for Liver Transplantation: a Pilot Study NCT03357900 | Hopital Foch | N/A |
| Completed | Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation W NCT01172691 | Baylor Research Institute | Phase 2 |
| Recruiting | Proteogenomic Monitoring and Assessment of Liver Transplant Recipients NCT01644903 | Northwestern University | — |
| Completed | Albumin, Total and Free Fraction of Mycophenolic Acid, and Measurement of IMPDH Activity in Liver Transplants. NCT00995956 | Oslo University Hospital | — |
| Completed | Intraoperative Glucose Control in Liver Transplant NCT00780026 | University of Michigan | Phase 4 |
| Withdrawn | Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients NCT01884038 | United Therapeutics | Phase 2 / Phase 3 |
| Completed | Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients NCT00698399 | Vanderbilt University Medical Center | — |
| Unknown | Systemic Variables in the Saliva of Children Undergoing Liver Transplantation NCT01307163 | Hadassah Medical Organization | — |
| Terminated | An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Stu NCT00371605 | University of Pittsburgh | — |
| Completed | Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients NCT00320606 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Terminated | Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacroli NCT00260208 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C NCT00275548 | Mayo Clinic | Phase 4 |
| Completed | Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients NCT00171509 | Novartis | Phase 4 |
| Completed | Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients NCT00171743 | Novartis | Phase 4 |
| Completed | Pediatric Liver Database NCT00677625 | Medical College of Wisconsin | — |
| Completed | Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients NCT00149994 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation NCT00238901 | Novartis | Phase 3 |